{"id": "61_18-0187_0", "title": "61_18-0187", "content": "Journal of Oral Science, Vol. 61, No. 2, 364-369, 2019", "contents": "61_18-0187. Journal of Oral Science, Vol. 61, No. 2, 364-369, 2019"}
{"id": "61_18-0187_1", "title": "61_18-0187", "content": "New method for postoperative pain relief using a combination of noxious and non-noxious stimuli after impacted wisdom tooth extraction Keiko Fujii-Abe1), Masahiro Umino2), Hiroshi Kawahara1), Chika Terada3), Kazuhito Satomura3), and Haruhisa Fukayama2) 1)Department of Dental Anesthesiology, School of Dental Medicine, Tsurumi University, Yokohama, Japan 2)Anesthesiology and Clinical Physiology, Graduate School, Tokyo Medical and Dental University, Tokyo, Japan 3)Department of Oral Medicine and Stomatology, School of Dental Medicine, Tsurumi University, Yokohama, Japan", "contents": "61_18-0187. New method for postoperative pain relief using a combination of noxious and non-noxious stimuli after impacted wisdom tooth extraction Keiko Fujii-Abe1), Masahiro Umino2), Hiroshi Kawahara1), Chika Terada3), Kazuhito Satomura3), and Haruhisa Fukayama2) 1)Department of Dental Anesthesiology, School of Dental Medicine, Tsurumi University, Yokohama, Japan 2)Anesthesiology and Clinical Physiology, Graduate School, Tokyo Medical and Dental University, Tokyo, Japan 3)Department of Oral Medicine and Stomatology, School of Dental Medicine, Tsurumi University, Yokohama, Japan"}
{"id": "61_18-0187_2", "title": "61_18-0187", "content": "3)Department of Oral Medicine and Stomatology, School of Dental Medicine, Tsurumi University, Yokohama, Japan (Received June 2, 2018; Accepted November 6, 2018)", "contents": "61_18-0187. 3)Department of Oral Medicine and Stomatology, School of Dental Medicine, Tsurumi University, Yokohama, Japan (Received June 2, 2018; Accepted November 6, 2018)"}
{"id": "61_18-0187_3", "title": "61_18-0187", "content": "Abstract: Although in clinical dentistry the major method used for pain relief is oral administration of analgesics, alternative methods are available, such as transcutaneous electrical nerve stimulation (TENS), acupuncture, vibration and conditioned pain modulation (CPM), formerly termed diffuse noxious inhibitory control. The aim of the present study was to investigate the combined effects of non-noxious (TENS) and noxious (CPM) stimuli on postoperative pain after extraction of an impacted wisdom tooth. The study involved 44 patients who were scheduled to undergo impacted wisdom tooth", "contents": "61_18-0187. Abstract: Although in clinical dentistry the major method used for pain relief is oral administration of analgesics, alternative methods are available, such as transcutaneous electrical nerve stimulation (TENS), acupuncture, vibration and conditioned pain modulation (CPM), formerly termed diffuse noxious inhibitory control. The aim of the present study was to investigate the combined effects of non-noxious (TENS) and noxious (CPM) stimuli on postoperative pain after extraction of an impacted wisdom tooth. The study involved 44 patients who were scheduled to undergo impacted wisdom tooth"}
{"id": "61_18-0187_4", "title": "61_18-0187", "content": "of non-noxious (TENS) and noxious (CPM) stimuli on postoperative pain after extraction of an impacted wisdom tooth. The study involved 44 patients who were scheduled to undergo impacted wisdom tooth extraction. The patients were randomly allocated into four groups: noxious stimuli, non-noxious stimuli, combined noxious and non-noxious stimuli, and a sham group. On the day after tooth extraction, stimulation proce- dures for pain relief were performed and changes in the level of perceived pain were scored using a visual analog scale (VAS). The combination of non-noxious and noxious stimuli", "contents": "61_18-0187. of non-noxious (TENS) and noxious (CPM) stimuli on postoperative pain after extraction of an impacted wisdom tooth. The study involved 44 patients who were scheduled to undergo impacted wisdom tooth extraction. The patients were randomly allocated into four groups: noxious stimuli, non-noxious stimuli, combined noxious and non-noxious stimuli, and a sham group. On the day after tooth extraction, stimulation proce- dures for pain relief were performed and changes in the level of perceived pain were scored using a visual analog scale (VAS). The combination of non-noxious and noxious stimuli"}
{"id": "61_18-0187_5", "title": "61_18-0187", "content": "stimulation proce- dures for pain relief were performed and changes in the level of perceived pain were scored using a visual analog scale (VAS). The combination of non-noxious and noxious stimuli decreased the VAS scores by", "contents": "61_18-0187. stimulation proce- dures for pain relief were performed and changes in the level of perceived pain were scored using a visual analog scale (VAS). The combination of non-noxious and noxious stimuli decreased the VAS scores by"}
{"id": "61_18-0187_6", "title": "61_18-0187", "content": "Correspondence to Dr. Keiko Fujii-Abe, Department of Dental Anesthesiology, School of Dental Medicine, Tsurumi University, 2-1-3 Tsurumi, Tsurumi-ku, Yokohama, Kanagawa 230-8501, Japan Fax: +81-45-573-9599 E-mail: fujii-keiko@tsurumi-u.ac.jp doi.org/10.2334/josnusd.18-0187 DN/JST.JSTAGE/josnusd/18-0187", "contents": "61_18-0187. Correspondence to Dr. Keiko Fujii-Abe, Department of Dental Anesthesiology, School of Dental Medicine, Tsurumi University, 2-1-3 Tsurumi, Tsurumi-ku, Yokohama, Kanagawa 230-8501, Japan Fax: +81-45-573-9599 E-mail: fujii-keiko@tsurumi-u.ac.jp doi.org/10.2334/josnusd.18-0187 DN/JST.JSTAGE/josnusd/18-0187"}
{"id": "61_18-0187_7", "title": "61_18-0187", "content": "63.7%, indicating a more potent analgesic effect than that in the non-noxious, noxious, and sham groups. This method of analgesia using a combination of non- noxious and noxious stimuli can be applied to patients who are unable to tolerate analgesics, such as those with allergy, hypersensitivity or digestive disorders, and those who are pregnant. Keywords: conditioned pain modulation; transcutaneous electrical nerve stimulation; impacted wisdom tooth extraction.", "contents": "61_18-0187. 63.7%, indicating a more potent analgesic effect than that in the non-noxious, noxious, and sham groups. This method of analgesia using a combination of non- noxious and noxious stimuli can be applied to patients who are unable to tolerate analgesics, such as those with allergy, hypersensitivity or digestive disorders, and those who are pregnant. Keywords: conditioned pain modulation; transcutaneous electrical nerve stimulation; impacted wisdom tooth extraction."}
{"id": "61_18-0187_8", "title": "61_18-0187", "content": "Introduction", "contents": "61_18-0187. Introduction"}
{"id": "61_18-0187_9", "title": "61_18-0187", "content": "In clinical dentistry, oral administration of analgesics is frequently used for pain relief (1). However, analgesics may cause a variety of side effects including hypersen- sitivity, digestive disorders, and hepatorenal disorders. Bronchospasm and anaphylaxis are particularly serious side effects of hypersensitivity (1). When delivered via the oral route, analgesics are absorbed from the gastroin- testinal tract, enter the portal venous blood, and thus pass through the liver before entering the systemic circulation for delivery to the receptors leading to metabolism (2) (Corbascio AN et al.", "contents": "61_18-0187. In clinical dentistry, oral administration of analgesics is frequently used for pain relief (1). However, analgesics may cause a variety of side effects including hypersen- sitivity, digestive disorders, and hepatorenal disorders. Bronchospasm and anaphylaxis are particularly serious side effects of hypersensitivity (1). When delivered via the oral route, analgesics are absorbed from the gastroin- testinal tract, enter the portal venous blood, and thus pass through the liver before entering the systemic circulation for delivery to the receptors leading to metabolism (2) (Corbascio AN et al."}
{"id": "61_18-0187_10", "title": "61_18-0187", "content": "testinal tract, enter the portal venous blood, and thus pass through the liver before entering the systemic circulation for delivery to the receptors leading to metabolism (2) (Corbascio AN et al. Pharmacokinetics and drug interac- tions, Drug Interactions in Anesthesia, Second Edition, 39-50, Lea & Febiger, Philadelphia, 1986). The first-pass effect through the liver thus greatly reduces the bioavail- ability of analgesics.", "contents": "61_18-0187. testinal tract, enter the portal venous blood, and thus pass through the liver before entering the systemic circulation for delivery to the receptors leading to metabolism (2) (Corbascio AN et al. Pharmacokinetics and drug interac- tions, Drug Interactions in Anesthesia, Second Edition, 39-50, Lea & Febiger, Philadelphia, 1986). The first-pass effect through the liver thus greatly reduces the bioavail- ability of analgesics."}
{"id": "61_18-0187_11", "title": "61_18-0187", "content": "Table 1 The background of the patients Combined TENS CPM Sham Age (years) 26.2 �� 4.97 25.3 �� 5.48 26.1 �� 3.43 27.5 �� 3.36 Gender (M:F) 6:5 5:6 5:6 5:6", "contents": "61_18-0187. Table 1 The background of the patients Combined TENS CPM Sham Age (years) 26.2 �� 4.97 25.3 �� 5.48 26.1 �� 3.43 27.5 �� 3.36 Gender (M:F) 6:5 5:6 5:6 5:6"}
{"id": "61_18-0187_12", "title": "61_18-0187", "content": "�@On the other hand, non-noxious stimulation, including electro-acupuncture and transcutaneous electrical nerve stimulation (TENS), can elicit analgesic effects without causing side effects (3,4) and is not subject to the first-pass effect. In addition to oral analgesics, electro-acupuncture (5,6) and TENS (7,8) have also been employed for pain relief because of these advantages.", "contents": "61_18-0187. �@On the other hand, non-noxious stimulation, including electro-acupuncture and transcutaneous electrical nerve stimulation (TENS), can elicit analgesic effects without causing side effects (3,4) and is not subject to the first-pass effect. In addition to oral analgesics, electro-acupuncture (5,6) and TENS (7,8) have also been employed for pain relief because of these advantages."}
{"id": "61_18-0187_13", "title": "61_18-0187", "content": "�@The phenomenon of ��pain inhibiting pain�� is a concept referred to collectively as CPM or, formerly, diffuse noxious inhibitory control (DNIC) (9). A series of CPM studies in humans (10-13) have shown that somatosensory evoked potentials (SEP) induced by painful electrical tooth stimulation were reduced by noxious stimulation of the forearm, accompanied by a decrease of tooth pain intensity, as estimated using a visual analog scale (VAS) (10-13). The last of those studies demonstrated reduc- tions in the magnitudes of both SEP amplitudes and VAS values using a combination of non-noxious", "contents": "61_18-0187. �@The phenomenon of ��pain inhibiting pain�� is a concept referred to collectively as CPM or, formerly, diffuse noxious inhibitory control (DNIC) (9). A series of CPM studies in humans (10-13) have shown that somatosensory evoked potentials (SEP) induced by painful electrical tooth stimulation were reduced by noxious stimulation of the forearm, accompanied by a decrease of tooth pain intensity, as estimated using a visual analog scale (VAS) (10-13). The last of those studies demonstrated reduc- tions in the magnitudes of both SEP amplitudes and VAS values using a combination of non-noxious"}
{"id": "61_18-0187_14", "title": "61_18-0187", "content": "as estimated using a visual analog scale (VAS) (10-13). The last of those studies demonstrated reduc- tions in the magnitudes of both SEP amplitudes and VAS values using a combination of non-noxious and noxious stimuli (13).", "contents": "61_18-0187. as estimated using a visual analog scale (VAS) (10-13). The last of those studies demonstrated reduc- tions in the magnitudes of both SEP amplitudes and VAS values using a combination of non-noxious and noxious stimuli (13)."}
{"id": "61_18-0187_15", "title": "61_18-0187", "content": "�@These results demonstrated that the combined stimuli exerted more potent analgesic effects than either non- noxious or noxious stimuli alone, suggesting that both TENS and CPM activate central mechanisms, including the endogenous opioid and descending pain inhibitory pathways. �@Although there have been many independent reports of pain relief with respect to TENS (5,7,8,14,15) and CPM (9,10-13,16-19), few reports (20,21) have described the combined effects of TENS and CPM in humans.", "contents": "61_18-0187. �@These results demonstrated that the combined stimuli exerted more potent analgesic effects than either non- noxious or noxious stimuli alone, suggesting that both TENS and CPM activate central mechanisms, including the endogenous opioid and descending pain inhibitory pathways. �@Although there have been many independent reports of pain relief with respect to TENS (5,7,8,14,15) and CPM (9,10-13,16-19), few reports (20,21) have described the combined effects of TENS and CPM in humans."}
{"id": "61_18-0187_16", "title": "61_18-0187", "content": "�@The aim of the present study was to investigate the combined effects of non-noxious and noxious stimuli on postoperative pain after extraction of an impacted wisdom tooth. Materials and Methods Patients", "contents": "61_18-0187. �@The aim of the present study was to investigate the combined effects of non-noxious and noxious stimuli on postoperative pain after extraction of an impacted wisdom tooth. Materials and Methods Patients"}
{"id": "61_18-0187_17", "title": "61_18-0187", "content": "Materials and Methods Patients Forty-four patients scheduled to undergo impacted wisdom tooth extraction participated, and none of them withdrew during the study period. Approval for the study was obtained from the ethics committee of Tsurumi University (No. 913; 12/9/2011). The patients comprised 21 males and 23 females aged between 20 and 34 years, with a mean age of 26.3 �� 6.36 years (�� SD) (Table1). As in the previous study (13), the 44 patients were randomly", "contents": "61_18-0187. Materials and Methods Patients Forty-four patients scheduled to undergo impacted wisdom tooth extraction participated, and none of them withdrew during the study period. Approval for the study was obtained from the ethics committee of Tsurumi University (No. 913; 12/9/2011). The patients comprised 21 males and 23 females aged between 20 and 34 years, with a mean age of 26.3 �� 6.36 years (�� SD) (Table1). As in the previous study (13), the 44 patients were randomly"}
{"id": "61_18-0187_18", "title": "61_18-0187", "content": "allocated to four groups, each comprising 11 patients: noxious stimuli (CPM), non-noxious stimuli (TENS), combined noxious and non-noxious stimuli (combined), and a sham group. Chi-squared test revealed no signifi- cant inter-group differences in gender ratio.", "contents": "61_18-0187. allocated to four groups, each comprising 11 patients: noxious stimuli (CPM), non-noxious stimuli (TENS), combined noxious and non-noxious stimuli (combined), and a sham group. Chi-squared test revealed no signifi- cant inter-group differences in gender ratio."}
{"id": "61_18-0187_19", "title": "61_18-0187", "content": "�@None of the subjects had any neurological, psychiatric, neuromuscular, endocrine, oral, or maxillofacial disease, and none were being treated concurrently with analgesic drugs including opioids, antidepressants, or cough suppressants. All of the subjects were fully informed of the study procedure and objectives, and provided written consent in accordance with the Declaration of Helsinki. Prior to participation, the subjects were informed that they were free to withdraw from the study at any time, that the study was designed to investigate the perception of pain, and that there was no", "contents": "61_18-0187. �@None of the subjects had any neurological, psychiatric, neuromuscular, endocrine, oral, or maxillofacial disease, and none were being treated concurrently with analgesic drugs including opioids, antidepressants, or cough suppressants. All of the subjects were fully informed of the study procedure and objectives, and provided written consent in accordance with the Declaration of Helsinki. Prior to participation, the subjects were informed that they were free to withdraw from the study at any time, that the study was designed to investigate the perception of pain, and that there was no"}
{"id": "61_18-0187_20", "title": "61_18-0187", "content": "Prior to participation, the subjects were informed that they were free to withdraw from the study at any time, that the study was designed to investigate the perception of pain, and that there was no possibility of tissue injury.", "contents": "61_18-0187. Prior to participation, the subjects were informed that they were free to withdraw from the study at any time, that the study was designed to investigate the perception of pain, and that there was no possibility of tissue injury."}
{"id": "61_18-0187_21", "title": "61_18-0187", "content": "Surgical procedure", "contents": "61_18-0187. Surgical procedure"}
{"id": "61_18-0187_22", "title": "61_18-0187", "content": "All mandibular wisdom tooth extractions were performed by a single specialist between 15:30 and 16:00 at the dental hospital of Tsurumi University. All patients were given an injection of 3.6 mL of 2% lidocaine with 12.5 ?g/ mL adrenaline (Showa Yakuhin Kako Co., Ltd., Tokyo, Japan; ORA) to the gingiva around the impacted mandib- ular wisdom tooth by the same specialist oral surgeon. All surgical procedures were performed under local infil- tration anesthesia without inferior alveolar nerve block. The mandibular wisdom teeth were classified as IA in 16 cases, class IB in 2 cases, class IIB in", "contents": "61_18-0187. All mandibular wisdom tooth extractions were performed by a single specialist between 15:30 and 16:00 at the dental hospital of Tsurumi University. All patients were given an injection of 3.6 mL of 2% lidocaine with 12.5 ?g/ mL adrenaline (Showa Yakuhin Kako Co., Ltd., Tokyo, Japan; ORA) to the gingiva around the impacted mandib- ular wisdom tooth by the same specialist oral surgeon. All surgical procedures were performed under local infil- tration anesthesia without inferior alveolar nerve block. The mandibular wisdom teeth were classified as IA in 16 cases, class IB in 2 cases, class IIB in"}
{"id": "61_18-0187_23", "title": "61_18-0187", "content": "procedures were performed under local infil- tration anesthesia without inferior alveolar nerve block. The mandibular wisdom teeth were classified as IA in 16 cases, class IB in 2 cases, class IIB in 22 cases, and class IIIC in 4 cases (Pell-Gregory classification). After local anesthesia had been achieved, the gingival mucosa and periosteum were incised and the mandibular bone was exposed. The bone was removed to allow access to the tooth root, and the tooth was extracted. During extrac- tion, the tooth was divided into pieces, if necessary. After exodontia, the remaining socket was cleaned", "contents": "61_18-0187. procedures were performed under local infil- tration anesthesia without inferior alveolar nerve block. The mandibular wisdom teeth were classified as IA in 16 cases, class IB in 2 cases, class IIB in 22 cases, and class IIIC in 4 cases (Pell-Gregory classification). After local anesthesia had been achieved, the gingival mucosa and periosteum were incised and the mandibular bone was exposed. The bone was removed to allow access to the tooth root, and the tooth was extracted. During extrac- tion, the tooth was divided into pieces, if necessary. After exodontia, the remaining socket was cleaned"}
{"id": "61_18-0187_24", "title": "61_18-0187", "content": "was removed to allow access to the tooth root, and the tooth was extracted. During extrac- tion, the tooth was divided into pieces, if necessary. After exodontia, the remaining socket was cleaned to remove any debris.", "contents": "61_18-0187. was removed to allow access to the tooth root, and the tooth was extracted. During extrac- tion, the tooth was divided into pieces, if necessary. After exodontia, the remaining socket was cleaned to remove any debris."}
{"id": "61_18-0187_25", "title": "61_18-0187", "content": "All patients were treated with prophylactic antibiotics (Astellas Pharma Inc., Tokyo, Japan; Cefdinir 100 mg) 4 and 16 hours after extraction. They were only allowed to take loxoprofen sodium hydrate tablet (Daiichi-Sankyo Co., Ltd., Tokyo, Japan; Loxonin 60 mg each) as an anal- gesic for severe postoperative pain between 20:00 and 24:00 on the surgical day. After 24:00, analgesic agents", "contents": "61_18-0187. All patients were treated with prophylactic antibiotics (Astellas Pharma Inc., Tokyo, Japan; Cefdinir 100 mg) 4 and 16 hours after extraction. They were only allowed to take loxoprofen sodium hydrate tablet (Daiichi-Sankyo Co., Ltd., Tokyo, Japan; Loxonin 60 mg each) as an anal- gesic for severe postoperative pain between 20:00 and 24:00 on the surgical day. After 24:00, analgesic agents"}
{"id": "61_18-0187_26", "title": "61_18-0187", "content": "Table 2 The intensity of the electrical stimuli Noxious Non-noxious Combined (V) 28.8 �� 6.39 13.2 �� 4.92 TENS (V) NA 12.0 �� 6.00 CPM (V) 25.1 �� 4.13 NA Sham NA NA NA: Not applicable", "contents": "61_18-0187. Table 2 The intensity of the electrical stimuli Noxious Non-noxious Combined (V) 28.8 �� 6.39 13.2 �� 4.92 TENS (V) NA 12.0 �� 6.00 CPM (V) 25.1 �� 4.13 NA Sham NA NA NA: Not applicable"}
{"id": "61_18-0187_27", "title": "61_18-0187", "content": "Noxious Non-noxious Combined (V) 28.8 �� 6.39 13.2 �� 4.92 TENS (V) NA 12.0 �� 6.00 CPM (V) 25.1 �� 4.13 NA Sham NA NA NA: Not applicable Fig. 1 Study design. A single operator carried out extraction of the mandibular wisdom teeth between 15:30 and 16:00. All patients received prophylactic antibiotics 4 and 16 h after. They were only allowed to take loxoprofen sodium hydrate tablet as an analgesic for severe postoperative pain until 24:00 on the surgical day. The stimulation procedure was performed between 9:00 and 12:00 on the day after extraction.", "contents": "61_18-0187. Noxious Non-noxious Combined (V) 28.8 �� 6.39 13.2 �� 4.92 TENS (V) NA 12.0 �� 6.00 CPM (V) 25.1 �� 4.13 NA Sham NA NA NA: Not applicable Fig. 1 Study design. A single operator carried out extraction of the mandibular wisdom teeth between 15:30 and 16:00. All patients received prophylactic antibiotics 4 and 16 h after. They were only allowed to take loxoprofen sodium hydrate tablet as an analgesic for severe postoperative pain until 24:00 on the surgical day. The stimulation procedure was performed between 9:00 and 12:00 on the day after extraction."}
{"id": "61_18-0187_28", "title": "61_18-0187", "content": "were prohibited. As a rescue plan if patients felt intoler- able pain, they were allowed to take analgesic agents at any time under the condition that if they did so, they would be withdrawn from the study.", "contents": "61_18-0187. were prohibited. As a rescue plan if patients felt intoler- able pain, they were allowed to take analgesic agents at any time under the condition that if they did so, they would be withdrawn from the study."}
{"id": "61_18-0187_29", "title": "61_18-0187", "content": "Stimulation procedures The stimulation procedures employed were all carried out by a single dental anesthesiologist using an originally developed device (Ohyou Keisoku Kenkyuusyo, Tokyo, Japan) described previously (13).", "contents": "61_18-0187. Stimulation procedures The stimulation procedures employed were all carried out by a single dental anesthesiologist using an originally developed device (Ohyou Keisoku Kenkyuusyo, Tokyo, Japan) described previously (13)."}
{"id": "61_18-0187_30", "title": "61_18-0187", "content": "�@According to Svensson et al. (22), conditioning stimulation exerts hypoalgesic effects when applied both contralateral and ipsilateral to a remote site. Here, the ipsilateral median nerve on the forearm was selected as the site for noxious stimulation. Non-noxious stimula- tion was applied to the buccal region innervated by the trigeminal nerve ipsilateral to the extracted tooth. As the anode, an electrically conductive rubber electrode (diameter 44 mm, area 15.2 mm2) with a solid gel (Red Dot, 3M Health Care, Tokyo, Japan) was placed on the skin above the median nerve 5 cm from the wrist,", "contents": "61_18-0187. �@According to Svensson et al. (22), conditioning stimulation exerts hypoalgesic effects when applied both contralateral and ipsilateral to a remote site. Here, the ipsilateral median nerve on the forearm was selected as the site for noxious stimulation. Non-noxious stimula- tion was applied to the buccal region innervated by the trigeminal nerve ipsilateral to the extracted tooth. As the anode, an electrically conductive rubber electrode (diameter 44 mm, area 15.2 mm2) with a solid gel (Red Dot, 3M Health Care, Tokyo, Japan) was placed on the skin above the median nerve 5 cm from the wrist,"}
{"id": "61_18-0187_31", "title": "61_18-0187", "content": "an electrically conductive rubber electrode (diameter 44 mm, area 15.2 mm2) with a solid gel (Red Dot, 3M Health Care, Tokyo, Japan) was placed on the skin above the median nerve 5 cm from the wrist, and as the cathode a similar electrode was placed on the buccal skin innervated by the trigeminal nerve 5 cm from the anode. A diameter of 44 mm was used to cover the whole", "contents": "61_18-0187. an electrically conductive rubber electrode (diameter 44 mm, area 15.2 mm2) with a solid gel (Red Dot, 3M Health Care, Tokyo, Japan) was placed on the skin above the median nerve 5 cm from the wrist, and as the cathode a similar electrode was placed on the buccal skin innervated by the trigeminal nerve 5 cm from the anode. A diameter of 44 mm was used to cover the whole"}
{"id": "61_18-0187_32", "title": "61_18-0187", "content": "area affected by extraction, including the site of swelling. For noxious stimulation, the intensity was determined as 1.2 times the minimum intensity of the stimulus at which a faint pain sensation was used. At this intensity, patients were able to feel a clear pain sensation. In the sham group, electrically conductive rubber electrodes were placed on the forearm and buccal skin, without delivery of an electrical current.", "contents": "61_18-0187. area affected by extraction, including the site of swelling. For noxious stimulation, the intensity was determined as 1.2 times the minimum intensity of the stimulus at which a faint pain sensation was used. At this intensity, patients were able to feel a clear pain sensation. In the sham group, electrically conductive rubber electrodes were placed on the forearm and buccal skin, without delivery of an electrical current."}
{"id": "61_18-0187_33", "title": "61_18-0187", "content": "Stimulus intensity The electrical non-noxious stimulation was applied at an intensity of 13.2 �� 4.92 V (mean �� SE) in the combined group and 12.0 �� 6.00 V (mean �� SE) in the TENS group with a duration of 500 �gs at intervals of 20 ms (Table 2). There was no significant difference between these two groups (Student��s t test).", "contents": "61_18-0187. Stimulus intensity The electrical non-noxious stimulation was applied at an intensity of 13.2 �� 4.92 V (mean �� SE) in the combined group and 12.0 �� 6.00 V (mean �� SE) in the TENS group with a duration of 500 �gs at intervals of 20 ms (Table 2). There was no significant difference between these two groups (Student��s t test)."}
{"id": "61_18-0187_34", "title": "61_18-0187", "content": "�@The electrical noxious simulation was applied at an intensity of 28.8 �� 6.39 V (mean �� SE) in the combined group and 25.1 �� 4.13 V (mean �� SE) in the CPM group with a duration of 1 ms at intervals of 100 ms. To avoid any stimulus expectation, these stimuli were applied randomly at any setting (Table 2). There was no signifi- cant difference between these two groups (Student��s t test).", "contents": "61_18-0187. �@The electrical noxious simulation was applied at an intensity of 28.8 �� 6.39 V (mean �� SE) in the combined group and 25.1 �� 4.13 V (mean �� SE) in the CPM group with a duration of 1 ms at intervals of 100 ms. To avoid any stimulus expectation, these stimuli were applied randomly at any setting (Table 2). There was no signifi- cant difference between these two groups (Student��s t test)."}
{"id": "61_18-0187_35", "title": "61_18-0187", "content": "Fig. 2 Changes in VAS scores. The degrees of reduction in the VAS scores in the combined and TENS groups were 63.7% and 46.5%, respectively. There were no significant differences in the pre- and post-stimulation VAS scores between the CPM and sham groups.", "contents": "61_18-0187. Fig. 2 Changes in VAS scores. The degrees of reduction in the VAS scores in the combined and TENS groups were 63.7% and 46.5%, respectively. There were no significant differences in the pre- and post-stimulation VAS scores between the CPM and sham groups."}
{"id": "61_18-0187_36", "title": "61_18-0187", "content": "�@The stimulation procedure was performed between 9:00 and 12:00 on the day after extraction (Fig.1). Electrical stimulation was applied to each patient for 20 min in the combined, the non-noxious and the noxious groups. In the sham group, as noted above, although an electrically conductive rubber electrode was placed on the forearm and the buccal skin, the subjects reclined for only 20 min without stimulation. �@Postoperative pain intensity in each group was estimated using a VAS before and after the stimulation treatment.", "contents": "61_18-0187. �@The stimulation procedure was performed between 9:00 and 12:00 on the day after extraction (Fig.1). Electrical stimulation was applied to each patient for 20 min in the combined, the non-noxious and the noxious groups. In the sham group, as noted above, although an electrically conductive rubber electrode was placed on the forearm and the buccal skin, the subjects reclined for only 20 min without stimulation. �@Postoperative pain intensity in each group was estimated using a VAS before and after the stimulation treatment."}
{"id": "61_18-0187_37", "title": "61_18-0187", "content": "Statistical analysis The VAS scores were expressed as the mean �� S.E. The Tukey-Kramer test was used to compare the pre- and post-stimulation VAS scores after repeated-measures ANOVA. Differences were considered statistically significant at P < 0.05. Statistical analysis was conducted using the SPSS 16.0 software package (SPSS Inc., Tokyo, Japan). Results Change in VAS score in the four groups", "contents": "61_18-0187. Statistical analysis The VAS scores were expressed as the mean �� S.E. The Tukey-Kramer test was used to compare the pre- and post-stimulation VAS scores after repeated-measures ANOVA. Differences were considered statistically significant at P < 0.05. Statistical analysis was conducted using the SPSS 16.0 software package (SPSS Inc., Tokyo, Japan). Results Change in VAS score in the four groups"}
{"id": "61_18-0187_38", "title": "61_18-0187", "content": "Results Change in VAS score in the four groups Tukey-Kramer test revealed no significant differences in the pre-VAS scores among the four groups (Fig. 2). The VAS scores decreased significantly from 38.8 �� 3.29 mm to 14.1 �� 3.22 mm after stimulation in the combined group (P < 0.01). The VAS scores in the non-noxious (TENS) group showed a significant decrease from 41.1 �� 4.09 mm to 22.1 �� 3.86 mm after stimulation (P < 0.05). The degrees of reduction in the VAS scores in the combined and the non-noxious (TENS) groups were 63.7% and", "contents": "61_18-0187. Results Change in VAS score in the four groups Tukey-Kramer test revealed no significant differences in the pre-VAS scores among the four groups (Fig. 2). The VAS scores decreased significantly from 38.8 �� 3.29 mm to 14.1 �� 3.22 mm after stimulation in the combined group (P < 0.01). The VAS scores in the non-noxious (TENS) group showed a significant decrease from 41.1 �� 4.09 mm to 22.1 �� 3.86 mm after stimulation (P < 0.05). The degrees of reduction in the VAS scores in the combined and the non-noxious (TENS) groups were 63.7% and"}
{"id": "61_18-0187_39", "title": "61_18-0187", "content": "46.5%, respectively. The difference in the degrees of pain reduction between these groups was significant (Student��s t test, P < 0.05). The VAS scores in the noxious group were 32.0 �� 3.99 mm for pre-stimulation and 21.0 �� 3.86 mm for post-stimulation. The corresponding VAS scores in the sham group were 32.5 �� 3.07 mm and 30.3 �� 3.37 mm, respectively. There were no significant changes in the pre- and post-stimulation VAS scores between in the noxious (CPM) and the sham groups.", "contents": "61_18-0187. 46.5%, respectively. The difference in the degrees of pain reduction between these groups was significant (Student��s t test, P < 0.05). The VAS scores in the noxious group were 32.0 �� 3.99 mm for pre-stimulation and 21.0 �� 3.86 mm for post-stimulation. The corresponding VAS scores in the sham group were 32.5 �� 3.07 mm and 30.3 �� 3.37 mm, respectively. There were no significant changes in the pre- and post-stimulation VAS scores between in the noxious (CPM) and the sham groups."}
{"id": "61_18-0187_40", "title": "61_18-0187", "content": "�@None of the study patients suffered any abnormal or harmful effects. No significant gender rate differences among the four groups (combined, TENS, CPM, and sham) were evident. Discussion", "contents": "61_18-0187. �@None of the study patients suffered any abnormal or harmful effects. No significant gender rate differences among the four groups (combined, TENS, CPM, and sham) were evident. Discussion"}
{"id": "61_18-0187_41", "title": "61_18-0187", "content": "Discussion This study showed that a combination of non-noxious and noxious stimuli decreased the VAS scores after wisdom tooth extraction by 63.7%, exerting an analgesic effect more potent than those in the non-noxious (TENS), noxious (CPM) and sham groups. This combination of non-noxious and noxious stimuli was more effective for nociceptive pain, such as postoperative pain, than non- noxious or noxious stimuli alone.", "contents": "61_18-0187. Discussion This study showed that a combination of non-noxious and noxious stimuli decreased the VAS scores after wisdom tooth extraction by 63.7%, exerting an analgesic effect more potent than those in the non-noxious (TENS), noxious (CPM) and sham groups. This combination of non-noxious and noxious stimuli was more effective for nociceptive pain, such as postoperative pain, than non- noxious or noxious stimuli alone."}
{"id": "61_18-0187_42", "title": "61_18-0187", "content": "�@A previous study had shown that a combination of non-noxious and noxious stimuli had a potent analgesic effect on tooth pain (13). The present findings support this previous observation, and suggest that the potent analgesic effect of combined non-noxious and noxious stimuli is elicited by segmental control and an activated central mechanism, including the endogenous opioid and descending pain inhibitory pathways (23) (Le Bars D et al., Opioids and diffuse noxious inhibitory control", "contents": "61_18-0187. �@A previous study had shown that a combination of non-noxious and noxious stimuli had a potent analgesic effect on tooth pain (13). The present findings support this previous observation, and suggest that the potent analgesic effect of combined non-noxious and noxious stimuli is elicited by segmental control and an activated central mechanism, including the endogenous opioid and descending pain inhibitory pathways (23) (Le Bars D et al., Opioids and diffuse noxious inhibitory control"}
{"id": "61_18-0187_43", "title": "61_18-0187", "content": "[DNIC] in the rat. Advances in Pain Research and Therapy, 517-539, Raven Press, Ltd., New York, 1995).", "contents": "61_18-0187. [DNIC] in the rat. Advances in Pain Research and Therapy, 517-539, Raven Press, Ltd., New York, 1995)."}
{"id": "61_18-0187_44", "title": "61_18-0187", "content": "�@Segmental and central control mechanisms elicited by non-noxious and noxious stimulation, respectively, provide additive enhancement of postoperative pain relief. Non-noxious stimulation is commonly used for pain relief as TENS, based on the gate control theory (14). Both high- and low-frequency TENS cause hypoalgesia through release of endogenous opioids in the CNS (8). TENS activates �g opioid receptors at low frequency and �_ opioid receptors at high frequency in the spinal cord and rostral ventral medulla (24). In humans, endogenous opioid peptides in cerebrospinal fluid are increased", "contents": "61_18-0187. �@Segmental and central control mechanisms elicited by non-noxious and noxious stimulation, respectively, provide additive enhancement of postoperative pain relief. Non-noxious stimulation is commonly used for pain relief as TENS, based on the gate control theory (14). Both high- and low-frequency TENS cause hypoalgesia through release of endogenous opioids in the CNS (8). TENS activates �g opioid receptors at low frequency and �_ opioid receptors at high frequency in the spinal cord and rostral ventral medulla (24). In humans, endogenous opioid peptides in cerebrospinal fluid are increased"}
{"id": "61_18-0187_45", "title": "61_18-0187", "content": "receptors at low frequency and �_ opioid receptors at high frequency in the spinal cord and rostral ventral medulla (24). In humans, endogenous opioid peptides in cerebrospinal fluid are increased by low- or high-frequency TENS (25,26).", "contents": "61_18-0187. receptors at low frequency and �_ opioid receptors at high frequency in the spinal cord and rostral ventral medulla (24). In humans, endogenous opioid peptides in cerebrospinal fluid are increased by low- or high-frequency TENS (25,26)."}
{"id": "61_18-0187_46", "title": "61_18-0187", "content": "�@Noxious stimuli can also elicit analgesic effects via activation of a central mechanism, a phenomenon referred to as CPM. This has also been proposed to play a major role in modulation of pain, whereby painful conditioning stimulation in one region inhibits pain in a remote area of the body (16,18). The central involvement of CPM trig- gered by peripheral A�_ and C fibers emanates from brain structures confined to the caudal-most part of the medulla", "contents": "61_18-0187. �@Noxious stimuli can also elicit analgesic effects via activation of a central mechanism, a phenomenon referred to as CPM. This has also been proposed to play a major role in modulation of pain, whereby painful conditioning stimulation in one region inhibits pain in a remote area of the body (16,18). The central involvement of CPM trig- gered by peripheral A�_ and C fibers emanates from brain structures confined to the caudal-most part of the medulla"}
{"id": "61_18-0187_47", "title": "61_18-0187", "content": "(10). The neural network of the CPM loop is present in the middle of the brainstem, including the raphe magnus, and mediated by the noradrenergic or serotonergic system (19). CPM is a form of supraspinal descending endogenous analgesia (27,28) that can be antagonized by a low dose of naloxone, an opiate antagonist (29). �@Combined non-noxious and noxious stimuli may lead to interaction of endogenous substances with opiate receptor sites, catecholaminergic, serotonergic, and opioid neuronal systems via noxious stimulation (13,19,29).", "contents": "61_18-0187. (10). The neural network of the CPM loop is present in the middle of the brainstem, including the raphe magnus, and mediated by the noradrenergic or serotonergic system (19). CPM is a form of supraspinal descending endogenous analgesia (27,28) that can be antagonized by a low dose of naloxone, an opiate antagonist (29). �@Combined non-noxious and noxious stimuli may lead to interaction of endogenous substances with opiate receptor sites, catecholaminergic, serotonergic, and opioid neuronal systems via noxious stimulation (13,19,29)."}
{"id": "61_18-0187_48", "title": "61_18-0187", "content": "�@The intensity of noxious stimulation employed in the present study was fully bearable by patients, the intensity being 1.2-fold that of a faint pain sensation. This intensity of noxious stimulation can be applied clinically.", "contents": "61_18-0187. �@The intensity of noxious stimulation employed in the present study was fully bearable by patients, the intensity being 1.2-fold that of a faint pain sensation. This intensity of noxious stimulation can be applied clinically."}
{"id": "61_18-0187_49", "title": "61_18-0187", "content": "�@To date, oral analgesic drugs have been used for post- operative pain relief after surgical removal of impacted wisdom teeth, as this approach is simple and non-inva- sive (1). However, orally administered analgesics can have potential side effects, including hypersensitivity, digestive disorders, and other issues (2). Analgesia using a combination of non-noxious and noxious stimuli can be an alternative to anti-inflammatory analgesics and narcotics for postoperative pain control after tooth extraction, and is expected to be useful for patients who develop hypersensitivity or digestive", "contents": "61_18-0187. �@To date, oral analgesic drugs have been used for post- operative pain relief after surgical removal of impacted wisdom teeth, as this approach is simple and non-inva- sive (1). However, orally administered analgesics can have potential side effects, including hypersensitivity, digestive disorders, and other issues (2). Analgesia using a combination of non-noxious and noxious stimuli can be an alternative to anti-inflammatory analgesics and narcotics for postoperative pain control after tooth extraction, and is expected to be useful for patients who develop hypersensitivity or digestive"}
{"id": "61_18-0187_50", "title": "61_18-0187", "content": "an alternative to anti-inflammatory analgesics and narcotics for postoperative pain control after tooth extraction, and is expected to be useful for patients who develop hypersensitivity or digestive disorders in response to analgesics, or for those who are pregnant. The present results may encourage new approaches for management of both acute and chronic pain in the dental,", "contents": "61_18-0187. an alternative to anti-inflammatory analgesics and narcotics for postoperative pain control after tooth extraction, and is expected to be useful for patients who develop hypersensitivity or digestive disorders in response to analgesics, or for those who are pregnant. The present results may encourage new approaches for management of both acute and chronic pain in the dental,"}
{"id": "61_18-0187_51", "title": "61_18-0187", "content": "oral, and maxillofacial regions. �@Finally, although there were no significant differ- ences in gender ratio between the present four groups (combined, TENS, CPM, and sham), it is well known that clinical and experimental pain studies have yielded consistent evidence of gender differences in pain percep- tion (30). However, some other studies including CPM (30,31) have demonstrated no significant differences in pain perception between genders. In the present study, as there were no significant differences in gender ratios, gender likely had little influence on the results. Acknowledgments", "contents": "61_18-0187. oral, and maxillofacial regions. �@Finally, although there were no significant differ- ences in gender ratio between the present four groups (combined, TENS, CPM, and sham), it is well known that clinical and experimental pain studies have yielded consistent evidence of gender differences in pain percep- tion (30). However, some other studies including CPM (30,31) have demonstrated no significant differences in pain perception between genders. In the present study, as there were no significant differences in gender ratios, gender likely had little influence on the results. Acknowledgments"}
{"id": "61_18-0187_52", "title": "61_18-0187", "content": "Acknowledgments This study was supported in part by a Grant-in-Aid for Scientific Research No. 18791485 from the Ministry of Education, Culture, Sports, Sciences and Technology Japan.", "contents": "61_18-0187. Acknowledgments This study was supported in part by a Grant-in-Aid for Scientific Research No. 18791485 from the Ministry of Education, Culture, Sports, Sciences and Technology Japan."}
{"id": "61_18-0187_53", "title": "61_18-0187", "content": "Conflict of interest The authors declare that there were no competing interests in relation to this study.", "contents": "61_18-0187. Conflict of interest The authors declare that there were no competing interests in relation to this study."}
{"id": "61_18-0187_54", "title": "61_18-0187", "content": "References 1. Nagi R, Yashoda Devi B.K., Rakesh N, Sujatha SR, Patil DJ (2015) Clinical implications of prescribing nonsteroidal anti- inflammatory drugs in oral health care�Xa review. Oral Surg, Oral Med, Oral Pathol, Oral Radiol 119, 264-271. 2. Elbadawy M, Sasaki K, Miyazaki Y, Aboubakr M, Khalil WF, Shimoda M (2015) Oral pharmacokinetics of acetaminophen to evaluate gastric emptying profiles of Shiba goats. J Vet Med Sci 77, 1331-1334.", "contents": "61_18-0187. References 1. Nagi R, Yashoda Devi B.K., Rakesh N, Sujatha SR, Patil DJ (2015) Clinical implications of prescribing nonsteroidal anti- inflammatory drugs in oral health care�Xa review. Oral Surg, Oral Med, Oral Pathol, Oral Radiol 119, 264-271. 2. Elbadawy M, Sasaki K, Miyazaki Y, Aboubakr M, Khalil WF, Shimoda M (2015) Oral pharmacokinetics of acetaminophen to evaluate gastric emptying profiles of Shiba goats. J Vet Med Sci 77, 1331-1334."}
{"id": "61_18-0187_55", "title": "61_18-0187", "content": "2. Elbadawy M, Sasaki K, Miyazaki Y, Aboubakr M, Khalil WF, Shimoda M (2015) Oral pharmacokinetics of acetaminophen to evaluate gastric emptying profiles of Shiba goats. J Vet Med Sci 77, 1331-1334. 3. Kasat V, Gupta A, Ladda R, Kathariya M, Saluja H, Faroogui AA (2014) Transcutaneous electric nerve stimulation (TENS) in dentistry�Xa review. J Clin and Exp Dent 6, e562-568.", "contents": "61_18-0187. 2. Elbadawy M, Sasaki K, Miyazaki Y, Aboubakr M, Khalil WF, Shimoda M (2015) Oral pharmacokinetics of acetaminophen to evaluate gastric emptying profiles of Shiba goats. J Vet Med Sci 77, 1331-1334. 3. Kasat V, Gupta A, Ladda R, Kathariya M, Saluja H, Faroogui AA (2014) Transcutaneous electric nerve stimulation (TENS) in dentistry�Xa review. J Clin and Exp Dent 6, e562-568."}
{"id": "61_18-0187_56", "title": "61_18-0187", "content": "3. Kasat V, Gupta A, Ladda R, Kathariya M, Saluja H, Faroogui AA (2014) Transcutaneous electric nerve stimulation (TENS) in dentistry�Xa review. J Clin and Exp Dent 6, e562-568. 4. Ozturk NK, Baki ED, Kavakli AS, Sahin AS, Ayoglu RU, Karaveli A et al. (2016) Comparison of transcutaneous electrical nerve stimulation and parasternal block for post- operative pain management after cardiac surgery. Pain Res Manag, doi.org/10.1155/2016/4261949�D", "contents": "61_18-0187. 3. Kasat V, Gupta A, Ladda R, Kathariya M, Saluja H, Faroogui AA (2014) Transcutaneous electric nerve stimulation (TENS) in dentistry�Xa review. J Clin and Exp Dent 6, e562-568. 4. Ozturk NK, Baki ED, Kavakli AS, Sahin AS, Ayoglu RU, Karaveli A et al. (2016) Comparison of transcutaneous electrical nerve stimulation and parasternal block for post- operative pain management after cardiac surgery. Pain Res Manag, doi.org/10.1155/2016/4261949�D"}
{"id": "61_18-0187_57", "title": "61_18-0187", "content": "Manag, doi.org/10.1155/2016/4261949�D 5. Cui HZ, Guang YH, Xiao HX, Ying W, Ming MZ, Wei W et al. (2013) Electro-acupuncture with different current intensi- ties to treat functional constipation: a study protocol for a randomized controlled trial. Trials 14, 344. 6. Javier M, Sandra C, Pilar S, Pedro V, Patricia H, Regina F et al. (2015) Electro-acupuncture for treatment of knee pain from osteoarthritis and the possible endocrinology changes: a study protocol for a randomized controlled trial. Trials 16, 248.", "contents": "61_18-0187. Manag, doi.org/10.1155/2016/4261949�D 5. Cui HZ, Guang YH, Xiao HX, Ying W, Ming MZ, Wei W et al. (2013) Electro-acupuncture with different current intensi- ties to treat functional constipation: a study protocol for a randomized controlled trial. Trials 14, 344. 6. Javier M, Sandra C, Pilar S, Pedro V, Patricia H, Regina F et al. (2015) Electro-acupuncture for treatment of knee pain from osteoarthritis and the possible endocrinology changes: a study protocol for a randomized controlled trial. Trials 16, 248."}
{"id": "61_18-0187_58", "title": "61_18-0187", "content": "7. Chapman CR, Benedetti C (1977) Analgesia following electrical stimulation and its partial reversal by a narcotic antagonist. Life Sci 21, 1645-1648. 8. Liebano RE, Rakel B, Vance CGT, Walsh DM, Sluka KA (2011) An investigation of the development of analgesic tolerance to TENS in humans. Pain 152, 335-342.", "contents": "61_18-0187. 7. Chapman CR, Benedetti C (1977) Analgesia following electrical stimulation and its partial reversal by a narcotic antagonist. Life Sci 21, 1645-1648. 8. Liebano RE, Rakel B, Vance CGT, Walsh DM, Sluka KA (2011) An investigation of the development of analgesic tolerance to TENS in humans. Pain 152, 335-342."}
{"id": "61_18-0187_59", "title": "61_18-0187", "content": "9. Yarnitsky D (2010) Conditioned pain modulation (the diffuse noxious inhibitory control-like effect): its relevance for acute and chronic pain states. Curr Opin in Anaesthesiol 23, 611-615. 10. Motohashi K, Umino M (2001) Heterotopic painful stimula- tion decreases the late component of somatosensory evoked potentials induced by electrical tooth stimulation. Cogn Brain Res 11, 39-46.", "contents": "61_18-0187. 9. Yarnitsky D (2010) Conditioned pain modulation (the diffuse noxious inhibitory control-like effect): its relevance for acute and chronic pain states. Curr Opin in Anaesthesiol 23, 611-615. 10. Motohashi K, Umino M (2001) Heterotopic painful stimula- tion decreases the late component of somatosensory evoked potentials induced by electrical tooth stimulation. Cogn Brain Res 11, 39-46."}
{"id": "61_18-0187_60", "title": "61_18-0187", "content": "10. Motohashi K, Umino M (2001) Heterotopic painful stimula- tion decreases the late component of somatosensory evoked potentials induced by electrical tooth stimulation. Cogn Brain Res 11, 39-46. 11. Fujii K, Motohashi K, Umino M (2006) Heterotopic ischemic pain attenuates somatosensory evoked potentials induced by electrical tooth stimulation: diffuse noxious inhibitory controls in the trigeminal nerve territory. Eur J Pain 10, 495-504.", "contents": "61_18-0187. 10. Motohashi K, Umino M (2001) Heterotopic painful stimula- tion decreases the late component of somatosensory evoked potentials induced by electrical tooth stimulation. Cogn Brain Res 11, 39-46. 11. Fujii K, Motohashi K, Umino M (2006) Heterotopic ischemic pain attenuates somatosensory evoked potentials induced by electrical tooth stimulation: diffuse noxious inhibitory controls in the trigeminal nerve territory. Eur J Pain 10, 495-504."}
{"id": "61_18-0187_61", "title": "61_18-0187", "content": "12. Oono Y, Fujii K, Motohashi K, Umino M (2008) Diffuse noxious inhibitory controls triggered by heterotopic CO2 laser conditioning stimulation decreased the SEP amplitudes induced by electrical tooth stimulation with different intensity at an equally inhibitory rate. Pain 136, 356-365. 13. Fujii-Abe K, Umino M, Fukayama H, Kawahara H (2016) Enhancement of analgesic effect by combination of non- noxious stimulation and noxious stimulation in humans. Pain Pract 16, 141-147. 14. Melzack R, Wall PD (1965) Pain mechanism: a new theory. Science 150, 971-979.", "contents": "61_18-0187. 12. Oono Y, Fujii K, Motohashi K, Umino M (2008) Diffuse noxious inhibitory controls triggered by heterotopic CO2 laser conditioning stimulation decreased the SEP amplitudes induced by electrical tooth stimulation with different intensity at an equally inhibitory rate. Pain 136, 356-365. 13. Fujii-Abe K, Umino M, Fukayama H, Kawahara H (2016) Enhancement of analgesic effect by combination of non- noxious stimulation and noxious stimulation in humans. Pain Pract 16, 141-147. 14. Melzack R, Wall PD (1965) Pain mechanism: a new theory. Science 150, 971-979."}
{"id": "61_18-0187_62", "title": "61_18-0187", "content": "14. Melzack R, Wall PD (1965) Pain mechanism: a new theory. Science 150, 971-979. 15. Sluka KA, Deacon M, Stibal A, Strissel S, Terpstra A (1999) Spinal blockage of opioid receptors prevents the analgesia produced by TENS in arthritic rats. The J Pharmacol and Exp Therap 289, 840-846. 16. Le Bars D, Chitour D, Clot AM (1981) The encoding of thermal stimuli by diffuse noxious inhibitory controls (DNIC). Brain Res 230, 394-399.", "contents": "61_18-0187. 14. Melzack R, Wall PD (1965) Pain mechanism: a new theory. Science 150, 971-979. 15. Sluka KA, Deacon M, Stibal A, Strissel S, Terpstra A (1999) Spinal blockage of opioid receptors prevents the analgesia produced by TENS in arthritic rats. The J Pharmacol and Exp Therap 289, 840-846. 16. Le Bars D, Chitour D, Clot AM (1981) The encoding of thermal stimuli by diffuse noxious inhibitory controls (DNIC). Brain Res 230, 394-399."}
{"id": "61_18-0187_63", "title": "61_18-0187", "content": "16. Le Bars D, Chitour D, Clot AM (1981) The encoding of thermal stimuli by diffuse noxious inhibitory controls (DNIC). Brain Res 230, 394-399. 17. Bouhassira D, Le Bars D, Bolgert F, Laplane D, Willer J (1993) Diffuse noxious inhibitory controls in humans: a neurophysiological investigation of patient with a form of Brown-Sequard syndrome. Ann Neurol 34, 536-543. 18. van Laarhoven AIM, Kraaimaat FW, Wilder-Smith OH, van de Kerkhof PCM, Evers AWM (2010) Heterotopic pruritic conditioning and itch- analogous to DNIC in pain? Pain 149, 332-337.", "contents": "61_18-0187. 16. Le Bars D, Chitour D, Clot AM (1981) The encoding of thermal stimuli by diffuse noxious inhibitory controls (DNIC). Brain Res 230, 394-399. 17. Bouhassira D, Le Bars D, Bolgert F, Laplane D, Willer J (1993) Diffuse noxious inhibitory controls in humans: a neurophysiological investigation of patient with a form of Brown-Sequard syndrome. Ann Neurol 34, 536-543. 18. van Laarhoven AIM, Kraaimaat FW, Wilder-Smith OH, van de Kerkhof PCM, Evers AWM (2010) Heterotopic pruritic conditioning and itch- analogous to DNIC in pain? Pain 149, 332-337."}
{"id": "61_18-0187_64", "title": "61_18-0187", "content": "18. van Laarhoven AIM, Kraaimaat FW, Wilder-Smith OH, van de Kerkhof PCM, Evers AWM (2010) Heterotopic pruritic conditioning and itch- analogous to DNIC in pain? Pain 149, 332-337. 19. Makino K, Kohase H, Sanada T, Umino M (2010) Phenyl- ephine suppresses the pain modulation of diffuse noxious inhibitory controls in rats. Anesth and Analg 110, 1215-1221. 20. Walker RH, Morris BA, Angulo DL, Schneider J, Colwell CW (1991) Postoperative use of continuous passive motion,", "contents": "61_18-0187. 18. van Laarhoven AIM, Kraaimaat FW, Wilder-Smith OH, van de Kerkhof PCM, Evers AWM (2010) Heterotopic pruritic conditioning and itch- analogous to DNIC in pain? Pain 149, 332-337. 19. Makino K, Kohase H, Sanada T, Umino M (2010) Phenyl- ephine suppresses the pain modulation of diffuse noxious inhibitory controls in rats. Anesth and Analg 110, 1215-1221. 20. Walker RH, Morris BA, Angulo DL, Schneider J, Colwell CW (1991) Postoperative use of continuous passive motion,"}
{"id": "61_18-0187_65", "title": "61_18-0187", "content": "transcutaneous electrical nerve stimulation, and continuous cooling pad following total knee arthroplasty. The J Arthropl 6, 151-156. 21. Liebano RE, Vance CG, Rakel BA, Lee JE, Cooper NA, Marchand S et al. (2013) Transcutaneous electrical nerve stimulation and conditioned pain modulation influence the perception of pain in humans. Eur J Pain 17, 1539-1546. 22. Svensson P, Hashikawa CH, Casey KL (1999) Site- and modality-specific modulation of experimental muscle pain in humans. Brain Res 851, 32-38.", "contents": "61_18-0187. transcutaneous electrical nerve stimulation, and continuous cooling pad following total knee arthroplasty. The J Arthropl 6, 151-156. 21. Liebano RE, Vance CG, Rakel BA, Lee JE, Cooper NA, Marchand S et al. (2013) Transcutaneous electrical nerve stimulation and conditioned pain modulation influence the perception of pain in humans. Eur J Pain 17, 1539-1546. 22. Svensson P, Hashikawa CH, Casey KL (1999) Site- and modality-specific modulation of experimental muscle pain in humans. Brain Res 851, 32-38."}
{"id": "61_18-0187_66", "title": "61_18-0187", "content": "22. Svensson P, Hashikawa CH, Casey KL (1999) Site- and modality-specific modulation of experimental muscle pain in humans. Brain Res 851, 32-38. 23. Pinto M, Castro AR, Tshudy F, Wilson SP, Lima D, Tavares I (2008) Opioids modulate pain facilitation from the dorsal reticular nucleus. Mole and Cell Neurosci 39, 508-518. 24. Sulka KA, Deacon M, Stibal A, Strissel S, Terpstra A (1999) Spinal blockade of opioid receptors prevents the analgesia produced by TENS in arthritic rats. The J Pharmacol and Exp Therap 289, 840-846.", "contents": "61_18-0187. 22. Svensson P, Hashikawa CH, Casey KL (1999) Site- and modality-specific modulation of experimental muscle pain in humans. Brain Res 851, 32-38. 23. Pinto M, Castro AR, Tshudy F, Wilson SP, Lima D, Tavares I (2008) Opioids modulate pain facilitation from the dorsal reticular nucleus. Mole and Cell Neurosci 39, 508-518. 24. Sulka KA, Deacon M, Stibal A, Strissel S, Terpstra A (1999) Spinal blockade of opioid receptors prevents the analgesia produced by TENS in arthritic rats. The J Pharmacol and Exp Therap 289, 840-846."}
{"id": "61_18-0187_67", "title": "61_18-0187", "content": "25. Salar G, Job I, Mingrino S, Bosio A, Trabucchi M (1981) Effect of transcutaneous electrotherapy on CSF �]-endorphin in patients without pain problems. Pain 10, 169-172. 26. Han JS, Chen XH, Sun SL, Xu XJ, Yuan Y, Yan SC et al. (1991) Effect of low- and high-frequency on met-enkephalin- arg-phe and dynorphin a immunoreactivity in human lumbar CSF. Pain 47, 295-298.", "contents": "61_18-0187. 25. Salar G, Job I, Mingrino S, Bosio A, Trabucchi M (1981) Effect of transcutaneous electrotherapy on CSF �]-endorphin in patients without pain problems. Pain 10, 169-172. 26. Han JS, Chen XH, Sun SL, Xu XJ, Yuan Y, Yan SC et al. (1991) Effect of low- and high-frequency on met-enkephalin- arg-phe and dynorphin a immunoreactivity in human lumbar CSF. Pain 47, 295-298."}
{"id": "61_18-0187_68", "title": "61_18-0187", "content": "26. Han JS, Chen XH, Sun SL, Xu XJ, Yuan Y, Yan SC et al. (1991) Effect of low- and high-frequency on met-enkephalin- arg-phe and dynorphin a immunoreactivity in human lumbar CSF. Pain 47, 295-298. 27. Granot M, Weissman-Fogel I, Crispel Y, Pud D, Granovsky Y, Sprecher E et al. (2008) Determinants of endogenous analgesia magnitude in a diffuse noxious inhibitory control (DNIC) paragram: do conditioning stimulus painfulness, gender and personality variables matter? Pain 136, 142-149.", "contents": "61_18-0187. 26. Han JS, Chen XH, Sun SL, Xu XJ, Yuan Y, Yan SC et al. (1991) Effect of low- and high-frequency on met-enkephalin- arg-phe and dynorphin a immunoreactivity in human lumbar CSF. Pain 47, 295-298. 27. Granot M, Weissman-Fogel I, Crispel Y, Pud D, Granovsky Y, Sprecher E et al. (2008) Determinants of endogenous analgesia magnitude in a diffuse noxious inhibitory control (DNIC) paragram: do conditioning stimulus painfulness, gender and personality variables matter? Pain 136, 142-149."}
{"id": "61_18-0187_69", "title": "61_18-0187", "content": "28. Moont R, Pud D, Sprecher E, Sharvit G, Yarnitsky D (2010) ��Pain inhibits pain�� mechanisms: is pain modulation simply due to distraction? Pain 150, 113-120. 29. Kraus E, Le Bars D, Besson JM (1981) Behavioral confir- mation of ��diffuse noxious inhibitory controla�� (DNIC) and evidence for a role of endogenous opiates. Brain Res 206, 495-499. 30. Baad-Hansen L, Poulsen HF, Jensen HM, Svensson P (2005) Lack of sex differences in modulation of experimental intra- oral pain by diffuse noxious inhibitory controls (DNIC). Pain 116, 359-365.", "contents": "61_18-0187. 28. Moont R, Pud D, Sprecher E, Sharvit G, Yarnitsky D (2010) ��Pain inhibits pain�� mechanisms: is pain modulation simply due to distraction? Pain 150, 113-120. 29. Kraus E, Le Bars D, Besson JM (1981) Behavioral confir- mation of ��diffuse noxious inhibitory controla�� (DNIC) and evidence for a role of endogenous opiates. Brain Res 206, 495-499. 30. Baad-Hansen L, Poulsen HF, Jensen HM, Svensson P (2005) Lack of sex differences in modulation of experimental intra- oral pain by diffuse noxious inhibitory controls (DNIC). Pain 116, 359-365."}
{"id": "61_18-0187_70", "title": "61_18-0187", "content": "30. Baad-Hansen L, Poulsen HF, Jensen HM, Svensson P (2005) Lack of sex differences in modulation of experimental intra- oral pain by diffuse noxious inhibitory controls (DNIC). Pain 116, 359-365. 31. Lautenbacher S, Kunz M, Burkhardt S (2008) The effects of DNIC-type inhibition on temporal summation compared to single pulse processing: does sex matter? Pain 140, 429-435.", "contents": "61_18-0187. 30. Baad-Hansen L, Poulsen HF, Jensen HM, Svensson P (2005) Lack of sex differences in modulation of experimental intra- oral pain by diffuse noxious inhibitory controls (DNIC). Pain 116, 359-365. 31. Lautenbacher S, Kunz M, Burkhardt S (2008) The effects of DNIC-type inhibition on temporal summation compared to single pulse processing: does sex matter? Pain 140, 429-435."}